Literature DB >> 19779888

Principles and overview of allogeneic hematopoietic stem cell transplantation.

Sergio Giralt1, Michael R Bishop.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19779888      PMCID： PMC6953421          DOI： 10.1007/978-0-387-78580-6_1

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  103 in total

1.  HL-A-identical marrow transplants in aplastic anemia, acute leukemia, and lymphosarcoma employing cyclophosphamide.

Authors:  G W Santos; L L Sensenbrenner; P N Anderson; P J Burke; D L Klein; R E Slavin; B Schacter; D S Borgaonkar
Journal:  Transplant Proc       Date:  1976-12       Impact factor: 1.066

2.  Leucocyte antibodies in sera from pregnant women.

Authors:  J J VAN ROOD; J G EERNISSE; A VAN LEEUWEN
Journal:  Nature       Date:  1958-06-21       Impact factor: 49.962

3.  Modification of irradiation injury in mice and guinea pigs by bone marrow injections.

Authors:  E LORENZ; D UPHOFF; T R REID; E SHELTON
Journal:  J Natl Cancer Inst       Date:  1951-08       Impact factor: 13.506

4.  Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation.

Authors:  R Childs; A Chernoff; N Contentin; E Bahceci; D Schrump; S Leitman; E J Read; J Tisdale; C Dunbar; W M Linehan; N S Young; A J Barrett
Journal:  N Engl J Med       Date:  2000-09-14       Impact factor: 91.245

5.  Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases.

Authors:  S Slavin; A Nagler; E Naparstek; Y Kapelushnik; M Aker; G Cividalli; G Varadi; M Kirschbaum; A Ackerstein; S Samuel; A Amar; C Brautbar; O Ben-Tal; A Eldor; R Or
Journal:  Blood       Date:  1998-02-01       Impact factor: 22.113

6.  Marrow harvesting from normal donors.

Authors:  C D Buckner; R A Clift; J E Sanders; P Stewart; W I Bensinger; K C Doney; K M Sullivan; R P Witherspoon; H J Deeg; F R Appelbaum
Journal:  Blood       Date:  1984-09       Impact factor: 22.113

7.  A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.

Authors:  J L Goodman; D J Winston; R A Greenfield; P H Chandrasekar; B Fox; H Kaizer; R K Shadduck; T C Shea; P Stiff; D J Friedman
Journal:  N Engl J Med       Date:  1992-03-26       Impact factor: 91.245

8.  A randomized phase III clinical trial of autologous blood stem cell transplantation comparing cryopreservation using dimethylsulfoxide vs dimethylsulfoxide with hydroxyethylstarch.

Authors:  S D Rowley; Z Feng; L Chen; L Holmberg; S Heimfeld; B MacLeod; W I Bensinger
Journal:  Bone Marrow Transplant       Date:  2003-06       Impact factor: 5.483

9.  Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.

Authors:  Philip J Bierman; John W Sweetenham; Fausto R Loberiza; Goli Taghipour; Hillard M Lazarus; J Douglas Rizzo; Norbert Schmitz; Koen van Besien; Julie M Vose; Mary Horowitz; Anthony Goldstone
Journal:  J Clin Oncol       Date:  2003-09-08       Impact factor: 44.544

10.  Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study.

Authors:  Adele K Fielding; Susan M Richards; Rajesh Chopra; Hillard M Lazarus; Mark R Litzow; Georgina Buck; I Jill Durrant; Selina M Luger; David I Marks; Ian M Franklin; Andrew K McMillan; Martin S Tallman; Jacob M Rowe; Anthony H Goldstone
Journal:  Blood       Date:  2006-10-10       Impact factor: 22.113
View more
  6 in total

1.  Personal resilience resources predict post-stem cell transplant cancer survivors' psychological outcomes through reductions in depressive symptoms and meaning-making.

Authors:  Rebecca A Campo; Lisa M Wu; Jane Austin; Heiddis Valdimarsdottir; Christine Rini
Journal:  J Psychosoc Oncol       Date:  2017-06-14

2.  National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee.

Authors:  Michael R Bishop; Edwin P Alyea; Mitchell S Cairo; J H Frederik Falkenburg; Carl H June; Nicolaus Kröger; Richard F Little; Jeffrey S Miller; Steven Z Pavletic; David L Porter; Stanley R Riddell; Koen van Besien; Alan S Wayne; Daniel J Weisdorf; Roy S Wu; Sergio Giralt
Journal:  Biol Blood Marrow Transplant       Date:  2011-01-09       Impact factor: 5.742

Review 3.  NK cell recognition of hematopoietic cells by SLAM-SAP families.

Authors:  Shasha Chen; Zhongjun Dong
Journal:  Cell Mol Immunol       Date:  2019-03-25       Impact factor: 11.530

4.  Impact of Low-Dose rATG Prior to Matched Sibling Donor Hematopoietic Stem Cell Transplantation for Hematologic Malignancies: Reduced Risk of Chronic Graft-versus-Host Disease and Improved Survival Outcomes.

Authors:  Zheng-Yang Song; Han-Yun Ren; Yu-Jun Dong; Yuan Li; Yue Yin; Yu-Hua Sun; Qian Wang; Wei-Lin Xu; Wei Liu; Jin-Ping Ou; Ze-Yin Liang
Journal:  Cancer Manag Res       Date:  2020-11-30       Impact factor: 3.989

5.  Management of Inborn Errors of Immunity in the Genomic Era.

Authors:  Doğa Damla Demir; Kosar Asnaashari; Nima Rezaei; Ahmet Özen
Journal:  Turk Arch Pediatr       Date:  2022-03

Review 6.  Promising Stem Cell therapy in the Management of HIV and AIDS: A Narrative Review.

Authors:  Usha Rani Kandula; Addisu Dabi Wake
Journal:  Biologics       Date:  2022-07-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.